Our analysis using objective estimation of total sleep and core AD CSF biomarkers as a proxy for dementia risk, strongly supports that those cognitively healthy elderly individuals with lower sleep time are potentially at greater risk of future neurodegenerative diseases based on higher t-tau and p-tau levels in the CSF. This evidence concerns the gene MAPT and Alzheimer disease.